Aptamer Group provides updates on its projects with Unilever, Neuro-Bio and AstraZeneca
05 Dec 2024
Technical update
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Technical update
Aptamer Group Plc (APTA:LON) | 0.5 0 0.0% | Mkt Cap: 18.1m
- Published:
05 Dec 2024 -
Author:
Barry Gibb -
Pages:
5 -
Aptamer Group provides updates on its projects with Unilever, Neuro-Bio and AstraZeneca